These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30560445)

  • 1. Clinical characteristics of avascular necrosis in patients with Behçet disease: a case series and literature review.
    Atas N; Bitik B; Varan O; Babaoglu H; Tufan A; Haznedaroglu S; Goker B; Ozturk MA
    Rheumatol Int; 2019 Jan; 39(1):153-159. PubMed ID: 30560445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes.
    Bakhshi Z; Yadav S; Harmsen WS; Edakkanambeth Varayil J; Karls KA; Tremaine WJ; Loftus EV
    Inflamm Bowel Dis; 2023 Aug; 29(8):1223-1230. PubMed ID: 36149260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
    Yang Y; Kumar S; Lim LS; Silverman ED; Levy DM
    J Rheumatol; 2015 Dec; 42(12):2304-9. PubMed ID: 26568601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avascular Necrosis of Bone in Patients with Uveitis Treated with Systemic Corticosteroids.
    Wong SW; Steeples LR; Jones NP
    Ocul Immunol Inflamm; 2022 May; 30(4):869-875. PubMed ID: 33539719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus.
    Sayarlioglu M; Yuzbasioglu N; Inanc M; Kamali S; Cefle A; Karaman O; Onat AM; Avan R; Cetin GY; Gul A; Ocal L; Aral O
    Rheumatol Int; 2012 Jan; 32(1):177-82. PubMed ID: 20711782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for avascular bone necrosis in systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    Br J Rheumatol; 1998 Aug; 37(8):895-900. PubMed ID: 9734682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors.
    Nevskaya T; Gamble MP; Pope JE
    Clin Exp Rheumatol; 2017; 35(4):700-710. PubMed ID: 28240590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of avascular necrosis in idiopathic inflammatory myopathies: a single-centre experience.
    Bourji KI; Mecoli CA; Paik JJ; Albayda J; Tiniakou E; Kelly W; Lloyd TE; Mammen A; Ahlawat S; Christopher-Stine L
    Rheumatology (Oxford); 2022 Mar; 61(3):936-942. PubMed ID: 34175928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pandemic is gone but its consequences are here to stay: avascular necrosis following corticosteroids administration for severe COVID-19.
    Migliorini F; Maffulli N; Shukla T; D'Ambrosi R; Singla M; Vaish A; Vaishya R
    J Orthop Surg Res; 2024 Feb; 19(1):135. PubMed ID: 38347592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study.
    Faezi ST; Hoseinian AS; Paragomi P; Akbarian M; Esfahanian F; Gharibdoost F; Akhlaghi M; Nadji A; Jamshidi AR; Shahram F; Nejadhosseinian M; Davatchi F
    Mod Rheumatol; 2015 Jul; 25(4):590-4. PubMed ID: 25528860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome.
    Mundo J; Peris P; Monegal A; Navasa M; Cervera R; Guañiabens N
    Lupus; 2006; 15(5):304-7. PubMed ID: 16761507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence, risk factors, and outcomes of symptomatic avascular necrosis of bone among Chinese pediatric patients with acute lymphoblastic leukemia.
    Hoo CPL; Leung AWK; Chan JPK; Cheung YT; Cheng FWT; Chow TTW; Lam GKS; Ha SY; Chiang AKS; Li RCH; Li CK
    Cancer Med; 2023 May; 12(9):10315-10325. PubMed ID: 37000036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral corticosteroid use and the risk of developing avascular necrosis: A large retrospective review.
    Grond SE; Little RE; Campbell DA; Loehrl TA; Poetker DM
    Int Forum Allergy Rhinol; 2022 Jul; 12(7):903-909. PubMed ID: 34918464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.
    Tse SM; Mok CC
    Lupus; 2017 Jun; 26(7):715-722. PubMed ID: 27831540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
    Shaharir SS; Chua SH; Mohd R; Mustafar R; Noh MM; Shahril NS; Said MSM; Rajalingham S
    PLoS One; 2021; 16(3):e0248845. PubMed ID: 33739994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
    Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
    Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies.
    Migliaresi S; Picillo U; Ambrosone L; Di Palma G; Mallozzi M; Tesone ER; Tirri G
    Lupus; 1994 Feb; 3(1):37-41. PubMed ID: 8025584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune diseases: a nationwide study.
    Tsai HL; Chang JW; Lu JH; Liu CS
    Korean J Intern Med; 2022 Jul; 37(4):864-876. PubMed ID: 35236014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avascular osteonecrosis after treatment of SARS: a 3-year longitudinal study.
    Lv H; de Vlas SJ; Liu W; Wang TB; Cao ZY; Li CP; Cao WC; Richardus JH
    Trop Med Int Health; 2009 Nov; 14 Suppl 1(Suppl 1):79-84. PubMed ID: 19508438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.